[go: up one dir, main page]

WO2008016730A3 - Compositions and methods for reducing cellular fat - Google Patents

Compositions and methods for reducing cellular fat Download PDF

Info

Publication number
WO2008016730A3
WO2008016730A3 PCT/US2007/067086 US2007067086W WO2008016730A3 WO 2008016730 A3 WO2008016730 A3 WO 2008016730A3 US 2007067086 W US2007067086 W US 2007067086W WO 2008016730 A3 WO2008016730 A3 WO 2008016730A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
reducing cellular
cellular fat
fat
Prior art date
Application number
PCT/US2007/067086
Other languages
French (fr)
Other versions
WO2008016730A2 (en
Inventor
Sarah S Bacus
Original Assignee
Targeted Molecular Diagnostics
Sarah S Bacus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Molecular Diagnostics, Sarah S Bacus filed Critical Targeted Molecular Diagnostics
Publication of WO2008016730A2 publication Critical patent/WO2008016730A2/en
Publication of WO2008016730A3 publication Critical patent/WO2008016730A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Methods are disclosed for the treatment of cells, such as adipocytes, to reduce their lipid content.
PCT/US2007/067086 2006-08-02 2007-04-20 Compositions and methods for reducing cellular fat WO2008016730A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US82123006P 2006-08-02 2006-08-02
US60/821,230 2006-08-02
US82737206P 2006-09-28 2006-09-28
US60/827,372 2006-09-28
US82834506P 2006-10-05 2006-10-05
US60/828,345 2006-10-05
US86773606P 2006-11-29 2006-11-29
US60/867,736 2006-11-29

Publications (2)

Publication Number Publication Date
WO2008016730A2 WO2008016730A2 (en) 2008-02-07
WO2008016730A3 true WO2008016730A3 (en) 2008-08-28

Family

ID=38997743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/067086 WO2008016730A2 (en) 2006-08-02 2007-04-20 Compositions and methods for reducing cellular fat

Country Status (1)

Country Link
WO (1) WO2008016730A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2011157827A1 (en) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2025502801A (en) 2021-12-30 2025-01-28 クライオサ， インク． Systems and methods for treating obstructive sleep apnea - Patents.com
WO2025090362A1 (en) * 2023-10-27 2025-05-01 Cryosa, Inc. Methods and systems for inducing apoptosis of adipose cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212034A1 (en) * 2001-06-11 2003-11-13 Winder William W Method of treatment of obesity and paralyzed muscle and ergogenic aids
US20050038068A1 (en) * 2003-05-16 2005-02-17 Iyengar Rajesh R. Thienopyridones as AMPK activators for the treatment of diabetes and obesity
US20060069117A1 (en) * 2002-11-05 2006-03-30 Sylvain Rault Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212034A1 (en) * 2001-06-11 2003-11-13 Winder William W Method of treatment of obesity and paralyzed muscle and ergogenic aids
US20060069117A1 (en) * 2002-11-05 2006-03-30 Sylvain Rault Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
US20050038068A1 (en) * 2003-05-16 2005-02-17 Iyengar Rajesh R. Thienopyridones as AMPK activators for the treatment of diabetes and obesity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRANDT ET AL.: "Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents", ONCOGENE, vol. 20, 2001, pages 5459 - 5465 *

Also Published As

Publication number Publication date
WO2008016730A2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2008016730A3 (en) Compositions and methods for reducing cellular fat
AP2011005777A0 (en) Methods and compositions related to thioesterase enzymes.
WO2008133722A3 (en) Anti human sclerostin antibodies
WO2008003007A3 (en) Compositions and methods for treating parasitic infections
WO2011066291A3 (en) Lyophilization methods, compositions, and kits
WO2009099719A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2010062863A3 (en) Compositions containing satiogens and methods of use
WO2009089494A3 (en) Pharmaceutical compositions
EP2705850A3 (en) Super fast-acting insulin compositions
EP2190307A4 (en) Preparation method of vegetable extract ferment solution and vegetable extract ferment solution prepared by the same
WO2010062762A3 (en) Compositions and methods for reducing the signs of aging of the skin
WO2007005758A3 (en) Methods , compositions and devices for promoting angiogenesis
WO2008106134A3 (en) Engineered anti-il-23r antibodies
IL211889A (en) Pyrazolo pyridine derivatives, compositions comprising the same and uses thereof as nadph oxidase inhibitors
WO2009085889A3 (en) Compositions and methods for reducing or preventing water loss from the skin
WO2008070616A3 (en) METHODS AND COMPOSITIONS RELATED TO HIF-1α
WO2008027600A3 (en) Imatinib compositions
WO2007095347A3 (en) Methods and compositions related to ghs-r antagonists
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
WO2007140205A3 (en) Methods of treating fibrosis
ZA200907240B (en) Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
WO2007041564A3 (en) (s)-6-methyloxaalkyl exemestane compounds and related methods of use
WO2010127197A3 (en) Method and composition for treating diabetic ketoacidosis
WO2009120700A3 (en) Inhibition of dcps
WO2010100570A3 (en) Activated leukocyte composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07761015

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07761015

Country of ref document: EP

Kind code of ref document: A2